Mobile Game Simulation for Nursing Students' Decision-Making

August 19, 2026 updated by: Delta University for Science and Technology

An Interactive Mobile Game-Based Simulation Educational Program for Enhancing Decision-Making and Problem-Solving Among Nursing Students: A Quasi-Experimental Study

This study will test whether an interactive mobile game-based simulation program helps first-year nursing students improve their decision-making and problem-solving skills. Students will complete knowledge, decision-making, and problem-solving assessments before and after taking part in a 4-week program (8 sessions) that uses mobile game scenarios to practice clinical decisions in a safe, simulated setting. The results will show whether this type of training is more effective than traditional teaching methods for building these skills.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This is a quasi-experimental, single-group, pretest-posttest study conducted at the Faculty of Nursing, Delta University for Science and Technology. The study tests three hypotheses: that participation in the program will significantly increase students' knowledge scores, clinical decision-making scores, and problem-solving scores from pre-test to post-test. The educational intervention progresses through four phases: assessment, planning, implementation, and evaluation. Outcomes will be measured using a researcher-developed knowledge questionnaire, the Clinical Decision-Making in Nursing Scale (CDMNS), and the Problem-Solving Inventory (PSI), administered at baseline, immediately after program completion, and again two months later.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
258

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • First-year nursing students at the Faculty of Nursing, Delta University for Science and Technology.
  • Students who voluntarily consent to participate in the study.
  • Students who are willing and able to use the mobile application.

Exclusion Criteria:

  • Students who have previously participated in a similar mobile game-based or simulation-based educational program.
  • Students with any condition that prevents them from using a smartphone/mobile application.
  • Students who fail to complete the pre-test, the educational program, or the post-test.
  • Students who withdraw consent during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Nursing Students Receiving Mobile Game-Based Simulation Program
First-year nursing students who receive the interactive mobile game-based simulation educational program over 4 weeks (8 sessions), twice per week, with each session lasting 2 hours. Assessments will be conducted at baseline, immediately after completion of the program, and 2 months after program completion.
Behavioral: Interactive Mobile Game-Based Simulation Educational Program
An interactive mobile game-based simulation educational program designed to enhance nursing students' clinical decision-making, knowledge about mobile game-based simulation, and problem-solving skills. The program will be implemented over 4 weeks through 8 sessions, twice per week, with each session lasting 2 hours. The program includes educational content, clinical scenarios, scenario-based decision-making, problem-solving activities, small group discussions, scenario debriefing, and hands-on use of the mobile application.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in Clinical Decision-Making Score
Time Frame: Baseline (before the educational program), immediately after completion of the program, and 2 months after program completion.
Clinical decision-making will be assessed using the Clinical Decision-Making in Nursing Scale (CDMNS). The scale consists of 40 items classified into four subscales: search for alternatives or options, canvassing of objectives and values, evaluation and re-evaluation of consequences, and search for information and unbiased assimilation of new information. Items are rated on a five-point Likert scale, with total scores ranging from 40 to 200. Higher scores indicate more positive clinical decision-making.
Baseline (before the educational program), immediately after completion of the program, and 2 months after program completion.
Change in Problem-Solving Score
Time Frame: Baseline (before the educational program), immediately after completion of the program, and 2 months after program completion.
Problem-solving will be assessed using the Problem-Solving Inventory (PSI). The inventory consists of 32 items classified into three subscales: problem-solving confidence, approach-avoidance style, and personal control. Items are rated on a six-point Likert scale, with reverse scoring for negative items. Total scores range from 32 to 192, with lower scores indicating more positive problem-solving perception.
Baseline (before the educational program), immediately after completion of the program, and 2 months after program completion.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change in Knowledge Score about Mobile Game-Based Simulation
Time Frame: Measured at baseline (before program), immediately after program completion (week 4), and 2 months after program completion
Measured using a researcher-developed questionnaire assessing students' knowledge of mobile game-based simulation, including its definition, development, advantages/disadvantages, technical requirements, and impact on nursing education. Scored 0 for incorrect and 1 for correct answers; classified as satisfactory (≥60%) or unsatisfactory (<60%).
Measured at baseline (before program), immediately after program completion (week 4), and 2 months after program completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Delta University for Science and Technology

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Mona Ahmed Gabr, PHD, Delta University for Science and Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Hwang, G. J., & Chang, C. Y. (2023). Facilitating decision-making performances in nursing treatments: A contextual digital game-based flipped learning approach. Interactive Learning Environments, 31(1), 156-171.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 15, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 15, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 19, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 20, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 19, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • DFM-IRB 00012367-26-07-022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings